Oncospace

by Sun Nuclear  · Based in United States → — Patient Safety Starts Here
Oncology

Regulatory Status Disclosed

Overview

Oncospace, now rebranded as Plan AI by Sun Nuclear, is a groundbreaking AI-powered data-mining system designed to enhance radiation therapy planning. Developed by Dr. Todd McNutt and his team at Johns Hopkins, it leverages artificial intelligence and machine learning to analyze the experiences of thousands of patients, helping radiation oncologists and dosimetrists craft optimal treatment plans tailored to individual needs while minimizing side effects.

The system provides an AI ‘assistant’ that predicts ideal doses and automatically creates AI-guided optimization objectives, integrating seamlessly with existing treatment planning systems like Varian Medical Systems® Eclipse™ and RaySearch RayStation®. Oncospace also offers a ‘Gateway’ solution for converting patient archives between different treatment planning systems.

Acquired by Sun Nuclear in April 2025, Plan AI aims to standardize and accelerate planning across institutions, ensuring high-quality, safe treatment and significantly streamlining workflows.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI and machine learning for radiation therapy planning
  • Predicts ideal dose and automatically creates AI-guided optimization objectives
  • Integrates with Varian Medical Systemsu00ae Eclipseu2122 and RaySearch RayStationu00ae
  • Treatment Planning Conversion (Gateway) for system migration
  • Predictive Plan Quality and Feasibility solution
  • Ready-to-use, FDA-cleared models trained on over 5,000 diverse cases
  • Cloud-based solution with enterprise-grade data security
  • Streamlined and intuitive interface for planning workflow
  • Supports expert planners by reducing variability and improving consistency
  • Provides patient-specific insights on achievable goals

Use Cases

  • Enhancing and standardizing radiation therapy planning
  • Optimizing patient outcomes in cancer treatment
  • Guiding dosimetry planning and plan optimization
  • Converting patient treatment planning archives between systems
  • Reducing planning time for radiation oncology teams
  • Improving consistency and quality of treatment plans

What Physicians Need to Know

Key Capabilities
Oncospace, now rebranded as Plan AI by Sun Nuclear, is an AI-powered solution that accelerates radiation therapy treatment planning and elevates plan quality. It uses machine learning to predict ideal dose distributions and automatically creates AI-guided optimization objectives for treatment planning systems. Plan AI can reduce planning time by up to 80% and aims to eliminate inter-planner variability. It offers pre-configured, U.S. FDA-cleared models for five body sites, trained on over 5,000 diverse cases, eliminating the need for in-house model development. The software helps create a common starting point for planning, predicts the best achievable plan, and integrates plan review tools for streamlined approval.
Clinical Utility
Plan AI assists radiation oncologists and dosimetrists by providing an AI 'assistant' that optimizes treatment plans to balance tumor control with protecting healthy tissue. It helps craft optimal treatment plans tailored to individual needs while minimizing side effects, drawing on a knowledge base built from the histories of over 5,000 patients. The tool is intended for use by qualified, trained radiation therapy professionals (medical physicists, oncologists, and dosimetrists) for configuring and reviewing radiotherapy treatment plans for various cancer types, including head and neck, thoracic, abdominal, and pelvic regions. It aims to raise the level of quality for all practices, allowing smaller practices to achieve the same standards as academic research institutions.
Integration Options
Plan AI is designed to complement existing treatment planning systems (TPS) rather than replace them. It offers seamless script-based integration with Varian Medical Systems® Eclipse™ and RaySearch RayStation®, preserving current optimization workflows while enhancing efficiency. Oncospace also offered a 'Gateway' solution for converting patient archives from Philips Pinnacle to systems like RaySearch RayStation and Varian Eclipse.
Compliance Status
Plan AI includes five FDA 510(k) cleared models for various body sites. It is also HIPAA/GDPR compliant, with EU data staying local and full encryption, and is ISO 27001 certified.
Pricing Model
Unknown
User Experience
Plan AI features minimal user input, utilizing pre-configured models to predict ideal doses and create AI-guided optimization objectives. The broader SunCHECK platform, which may integrate Oncospace solutions, features a user-friendly interface with an intuitive Worklist for at-a-glance views of tasks and system status, aiming to streamline and simplify access to essential Quality Management matters.
Support Quality
Sun Nuclear emphasizes ongoing support to ease technology adoption, enhance workflows, and improve outcomes. Public resources for technical evaluation of Plan AI, including webinars and datasheets, are provided.
Implementation Complexity
Plan AI utilizes ready-to-use, FDA-cleared models, meaning no model building is required by the user, which simplifies implementation. It is a cloud-native software application.
Evidence Base
Oncospace (now Plan AI) was developed by Dr. Todd McNutt and his team at Johns Hopkins, leveraging a data-mining system built from thousands of patient experiences. The AI models are trained on over 5,000 diverse cases. Internal studies have demonstrated up to an 80% reduction in planning time with Plan AI. Research presented at ESTRO 2026 indicated that Plan AI achieved non-inferior target coverage and consistent OAR sparing after a single, unattended optimization, suggesting its potential to standardize and accelerate planning.
Physician Tip

Plan AI (formerly Oncospace) can significantly streamline your radiation therapy planning workflow by providing AI-predicted optimal dose objectives and reducing manual iterations. Leverage its FDA-cleared, pre-trained models to quickly generate high-quality, consistent plans across your department, potentially freeing up time for more complex cases or patient interaction. The tool's ability to predict the best achievable plan before you even begin planning can help set realistic expectations and improve plan quality from the outset. Its integration with existing TPS like Eclipse and RayStation means it can be incorporated without disrupting established workflows.

Plan AI is designed for seamless, script-based integration with Varian Medical Systems® Eclipse™ and RaySearch RayStation® to enhance existing treatment planning workflows. Additionally, the legacy Oncospace 'Gateway' solution facilitated the conversion of patient archives from Philips Pinnacle to these modern treatment planning systems.

Details

Category Oncology AI
Pricing Unknown
DeploymentCloud-based
Compliance
BAA Available Yes AI-estimated
HIPAA Compliant Yes AI-estimated
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Oncology

Support & Reliability

FDA clearance history

This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.

Decision dateNumberName as listed by FDA
2025-04-11K242748 510(k)Oncospace

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Oncospace

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for Oncospace.

View all on YouTube

Frequently Asked Questions

Oncospace, now known as Plan AI by Sun Nuclear, is an AI-powered treatment planning assistant that helps radiation oncologists and dosimetrists create optimal radiation therapy plans. It analyzes data from thousands of prior patient cases to predict achievable dosimetric goals, aiming to improve plan quality and efficiency while minimizing side effects.
Physicians' concerns about AI in oncology include potential depersonalization of care, patient privacy, and algorithmic bias, especially if AI models are not trained on diverse patient populations. There are also challenges related to the rapid pace of AI development, the sheer number of available tools, and the risk of over-reliance on AI-generated outputs, which could impact clinical decision-making and information retention.
Oncospace (Plan AI) has received U.S. FDA clearance for multiple cancer types, including prostate, gynecological, head and neck, liver, pancreatic, lung, and esophageal cancers. It is intended for prescription use by qualified, trained radiation therapy professionals and is DICOM-RT compliant.
While Oncospace (Plan AI) offers a unique approach by providing pre-configured, FDA-cleared models, other oncology EHR vendors and AI solutions exist. These include specialized oncology modules within larger EHR systems like Epic Beacon and Cerner PowerChart Oncology, as well as dedicated platforms like Flatiron Health's OncoEMR, Elekta MOSAIQ, and Varian Aria.
While Oncospace (Plan AI) aims to streamline treatment planning, a general limitation of AI in oncology is the need for rigorous clinical validation and addressing algorithmic bias, particularly if training data lacks diversity. The system is designed to complement existing treatment planning systems rather than replace them, and it's up to the user to determine its applicability for individual patients.

Related Tools

VERITON CT 400 Series Digital SPECT/CT System (VERITON CT 416/464)
Spectrum Dynamics Medical
Oncology AI
The VERITON CT 400 Series is a digital SPECT/CT system with a 360-degree gantry and 12 swiveling CZT detectors, offering high sensitivity and quantitative accuracy for a wide range of nuclear medicine applications, including advanced theranostics imaging.
syngo.via MI Workflows, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, syngo MBF is an intelligent, integrated imaging software that helps address the challenges of interpreting, managing, and sharing complex data from molecular imaging scanners, providing automated workflows and advanced visualization for various clinical applications.
syngo.via MI WorkFlows, Scenium, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, Scenium, and syngo MBF are medical diagnostic post-processing applications for viewing, manipulation, quantification, analysis, and comparison of PET or nuclear-medicine functional data with CT or MR anatomical data across timepoints, supporting disease management and radiotherapy treatment planning by trained healthcare professionals.
BIOGRAPH One
Siemens Healthineers AG
Oncology AI
BIOGRAPH One is a second-generation PET/MR scanner designed to transform PET/MR image quality for a new era, combining high PET precision with powerful MR performance. It enables simultaneous visualization of organ location, function, and cellular metabolism, offering faster image acquisition times and more efficient workflows than previous generations of PET/MR scanners.
Claire™ OCT System
Perimeter Medical Imaging AI
Oncology AI
Perimeter Medical Imaging AI is a medical technology company driven to transform cancer surgery with ultra-high resolution, real-time, advanced imaging tools that address unmet medical needs.S. for intraoperative breast cancer margin assessment.
syngo.via RT Image Suite VC10
Varian Medical Systems, Inc.
Clinical Decision Support & Reference
syngo.via RT Image Suite VC10 offers advanced imaging and workflow solutions for precise and efficient radiation therapy planning.

See all Oncology AI tools →

Suggest an Edit → | Report an issue | Last Verified: 2026-11-11 | First Added: 2026-04-18
AI Tool Finder
AI-powered search. Results may not be comprehensive.